Casandra
Casandra Test Code PG98081Version 1 (DRAFT)
Performing Lab
Noonan Spectrum Disorders/RASopathies Panel
Clinical Use
Order TestUse
This test is aimed at individuals who exhibit relevant features or have a clinical or suspected diagnosis of Noonan syndrome or related RASopathies. It is also suitable for individuals who have received negative results from previous limited RASopathy gene testing.
Special Instructions
Not provided.
Limitations
The tests developed and validated by PreventionGenetics have not been cleared or approved by the US Food and Drug Administration. It is important to consider these limitations when interpreting the test results. Please consult with a healthcare provider for further guidance.
Test Details
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Mutation (23 genes)
BRAFCBLHRASKRASMAP2K1MAP2K2NRASPTPN11RAF1RIT1SHOC2SOS1SOS2SPRED1A2ML1AHRARHGAP35CELSR1CUL3HNRNPH1NF1SOS1PPP1CB
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided